Spots Global Cancer Trial Database for Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
Official Title: An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell Carcinoma
Study ID: NCT04470726
Interventions
Study Description
Brief Summary: To evaluate safety and efficacy of AIV001 treatment on low-risk basal cell carcinoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
California Dermatology & Clinical Research Institute, Encinitas, California, United States
Island Dermatology, Newport Beach, California, United States
Austin Institute for Clinical Research, Pflugerville, Texas, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
